X

Vous n'êtes pas connecté

Rubriques :

Maroc Maroc - DRUGS.COM - Pharma Industry News - 18/Sep 22:23

FDA Approves Ebglyss for Moderate-to-Severe Atopic Dermatitis

WEDNESDAY, Sept. 18, 2024 -- The U.S. Food and Drug Administration has approved Ebglyss (lebrikizumab-lbkz) for adults and children aged 12 years and older with moderate-to-severe atopic dermatitis.The targeted interleukin-13 inhibitor is...

Articles similaires

Sorry! Image not available at this time

Monthly News Roundup - October 2024

drugs.com - 31/Oct 00:10

FDA Approves AbbVie’s Vyalev to Treat Advanced Parkinson Disease In October, the US Food and Drug Administration (FDA) approved Vyalev...

Sorry! Image not available at this time

FDA Approves Aucatzyl (obecabtagene autoleucel) for Adults with Relapsed/Refractory B-Cell Acute Lymphoblastic Leukemia

drugs.com - 08/Nov 21:11

LONDON, Nov. 08, 2024 (GLOBE NEWSWIRE) -- Autolus Therapeutics plc (Nasdaq: AUTL), an early-commercial stage biopharmaceutical company developing...

Sorry! Image not available at this time

Lexicon Announces Outcome of FDA Advisory Committee for Zynquista (sotagliflozin) as an Adjunct to Insulin Therapy for Glycemic Control in Adults with Type 1 Diabetes and Chronic Kidney Disease

drugs.com - 31/Oct 21:10

THE WOODLANDS, Texas, October 31, 2024 -- Lexicon Pharmaceuticals, Inc. (Nasdaq: LXRX) today announced the outcome of the U.S. Food and Drug...

Sorry! Image not available at this time

Shorla Oncology Announces U.S. FDA Expanded Approval of Jylamvo (methotrexate), an Oncology and Autoimmune Drug for Pediatric Indications

drugs.com - 29/Oct 10:10

CAMBRIDGE, Mass.--(BUSINESS WIRE) October 29, 2024 --Shorla Oncology (‘Shorla’), a U.S.-Ireland specialty pharmaceutical company,...

Sorry! Image not available at this time

Abeona Therapeutics Completes Pz-cel Biologics License Application Resubmission to U.S. Food and Drug Administration

drugs.com - 29/Oct 22:10

CLEVELAND, Oct. 29, 2024 (GLOBE NEWSWIRE) -- Abeona Therapeutics Inc. (Nasdaq: ABEO) today announced that the Company has resubmitted its Biologics...

Sorry! Image not available at this time

Ionis Announces FDA Acceptance of New Drug Application for Donidalorsen for Prophylactic Treatment of HAE

drugs.com - 04/Nov 23:11

CARLSBAD, Calif., Nov. 4, 2024 /PRNewswire/ -- Ionis Pharmaceuticals, Inc. (Nasdaq: IONS) announced today that the U.S. Food and Drug Administration...

Sorry! Image not available at this time

PTC Therapeutics Announces FDA Acceptance of Translarna NDA Resubmission

drugs.com - 30/Oct 05:10

WARREN, N.J., Oct. 30, 2024 /PRNewswire/ -- PTC Therapeutics, Inc. (NASDAQ: PTCT) announced today the U.S. Food and Drug Administration (FDA) has...

Sorry! Image not available at this time

FDA Approves Emrosi (minocycline hydrochloride) for the Treatment of Rosacea

drugs.com - 04/Nov 00:11

SCOTTSDALE, Ariz., Nov. 04, 2024 (GLOBE NEWSWIRE) -- Journey Medical Corporation (Nasdaq: DERM) (“Journey Medical”), a commercial-stage...

Sorry! Image not available at this time

2ONE Labs Receives PMTA ‘Acceptance’ for 2ONE® Nicotine Pouch brand from FDA Center for Tobacco Products

arabnewsnetwork.ps - 29/Oct 13:54

LAKE TAHOE, Nev., Oct. 29, 2024 (GLOBE NEWSWIRE) — 2ONE Labs Inc., is pleased to announce the ‘Acceptance’ of its Premarket Tobacco Product...

Sorry! Image not available at this time

2ONE Labs Receives PMTA ‘Acceptance’ for 2ONE® Nicotine Pouch brand from FDA Center for Tobacco Products

mideastnews.ae  - 29/Oct 13:54

LAKE TAHOE, Nev., Oct. 29, 2024 (GLOBE NEWSWIRE) — 2ONE Labs Inc., is pleased to announce the ‘Acceptance’ of its Premarket Tobacco Product...

Les derniers communiqués